Lane announced an investment to increase the capacity of an ethoxy chemical plant in China
Expanding existing production capacity for personal and home care, and industrial applications
Invest in the formation of a new hub for Clariant's global healthcare business
Clariant will expand its care chemicals plant in Daya Bay, Huizhou, China, to strengthen support for customers in pharmaceutical, personal and home care, and industrial applications.
The investment of CHF 80 million will be completed by the end of 2024 with a view to increasing the production capacity of existing products and introducing new products. After successfully obtaining the GMP certificate for drugs, Clariant's Daya Bay production site has become the first API manufacturer in China to obtain polyethylene glycol Polyglykol 3350 certification. The facility will also serve as a hub for the new Clariant's global healthcare business, supplying high-quality ingredients to medicines that support healthcare at a faster pace.
"Clariant's continued commitment to strategic business development and support for our customers is exemplified by the successful manufacturing and registration of pharmaceutical-grade PEGs, as well as the resilience of our business," said Zhigang Miao, Global Vice President, Industrial Applications Business Unit, Clariant Care Chemicals.
Clariant will also expand its existing production capacity in Daya Bay with ethylene oxide (EODs) and a broad portfolio of chemicals. With faster production and more sustainable ingredients, we help customers advance their environmental goals and create differentiated, more sustainable solutions that meet industry needs. For example, plant-based Hostapon® mild surfactants with the EcoTain® label develop gentler, cleaner beauty products for personal care brands and formulators in products such as solid beauty sticks, shower gels and cream-based shampoos.
"Many of the industries we serve in Daya Bay are constantly evolving, reflecting changing sustainability goals and end-product performance needs, and we want to bring our innovation and expertise closer to our customers and drive their growth," commented Christian Wang, Global President, Clariant Care Chemicals. "Daya Bay is home to Clariant's first ethoxy plant in Asia, and with these investments, we will take advantage of the proximity of the plant to our main manufacturing site and upgrade it to a multi-purpose plant/ethylene oxide derivatives production site. This underscores our commitment to supporting our customers' success with more indigenous innovative chemistry. ”
Clariant already made a series of investments in Daya Bay prior to the Care Chemicals business unit's investment in strengthening its ethoxy chemical plant in China. In October 2022, Clariant announced that it will add a second line to its future halogen-free flame retardant additive plant, the first of which is currently under construction and scheduled to be operational in mid-2023, with a second line due in 2024.
Clariant's management team and representatives from local governments, customers and partners witnessed the groundbreaking ceremony
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The Most Striking Thing in BASF’s 2025 Results Isn’t Profit — It’s “Cutting Weight” and “Stopping the Bleeding” at the Same Time
-
BASF Moves to Sell 4,400 Employee Homes—Union Fury Reveals the Survival Math of a Chemical Giant
-
A Comprehensive Overview of China’s Special Engineering Materials Market: How Should the Industry Rebuild Its Capabilities Amid Growing Downstream Pressure?
-
Tinergy Chemical Invests 11 Billion Yuan, Phosphate Iron Becomes New Strategic Focus
-
BASF Evaluates New MDI Production Complex in India, Secures Dahej Site
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
Recommend Reading
-
Nylon Giant to Close Another European Plant, Cutting 140 Jobs
-
Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China
-
Fracturing the Crown: BASF Antwerp’s 600-Job Cut and the Global Alarm
-
Unilever Reports Stronger Margins and Accelerated Portfolio Transformation in FY2025
-
Yara’s Green Surge: Record Profits Fuelled by Precision, Not Just Prices
-
Geopolitical Risks in the Middle East Escalate: An Analysis of the Impact on the Acrylic Market
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
Escalation of Middle East Conflict Drives Significant Increase in China's Gasoline and Diesel Prices
-
On March 3rd, the market price of pure benzene in China continued to rise
-
Supply and Demand Improve, Cyclohexanone Market Rises in February in China